What is Ozempic?
Ozempic injection is approved alongside diet and exercise to improve blood-sugar control in adults with type 2 diabetes.[1]
See the uses & detailsOzempic injection contains semaglutide. When blood sugar is high, it helps the pancreas release more insulin and less glucagon. These signals help move sugar into tissues and reduce sugar released by the liver.[1][1][2][1][3]
semaglutide · generic name[1]
This page is specific to semaglutide injection sold as Ozempic.
Video playback is unavailable in this browser. The written explanation remains below.
Original 60-second, 16:9 silent prototype. Its ending says Educational prototype. Read the written explanation, sources and review status below.
Read the scene-by-scene visual alternativeOzempic injection is approved alongside diet and exercise to improve blood-sugar control in adults with type 2 diabetes.[1]
See the uses & detailsOzempic injection contains semaglutide. When blood sugar is high, it helps the pancreas release more insulin and less glucagon. These signals help move sugar into tissues and reduce sugar released by the liver.[1][1][2][1][3]
Commonly listed side effects include nausea, vomiting, diarrhea, constipation and abdominal pain. Read the Medication Guide for fuller safety information.[1][2]
Side effects vary. These are selected examples, not the full list.
Know the important watch-outsOzempic (semaglutide) injection only. This article focuses on glucose control in adults with type 2 diabetes. It does not cover Ozempic tablets, Wegovy, weight-loss treatment or other semaglutide products, and does not describe every approved use of Ozempic injection.[1]
Original storyboard wording and timing are preserved below. Motion is schematic, not a measured clinical result. The chosen silent master has no audio; storyboard references to music describe the alternate original soundtrack.
How does Ozempic lower blood sugar?
Blood-sugar control
Visual: Glucose particles move through a schematic bloodstream. No efficacy number, blood-sugar target or before/after normalization is shown.
Semaglutide activates GLP-1 receptors.
GLP-1 is a hormone that helps regulate blood sugar.
Visual: A labeled semaglutide particle docks at a schematic cell-surface receptor, followed by an activation pulse.
When blood sugar is high
The pancreas releases more insulin.
Insulin is a hormone.
Visual: The pancreas releases distinct cyan insulin signals toward a labeled muscle cell.
When blood sugar is high
Insulin helps cells take up sugar.
Sugar moves from the blood into body tissues.
Visual: After the insulin signal reaches the muscle cell, orange glucose particles enter the cell. Blood keeps flowing.
When blood sugar is high
Glucagon tells the liver to release sugar.
Visual: Glucagon signals travel from the pancreas toward the liver. Glucose leaves the liver and enters the blood.
When blood sugar is high
Less glucagon. Less sugar released.
Semaglutide reduces glucagon release.
Visual: Signal frequency and glucose release are reduced, not stopped. Particle counts and motion are qualitative, not clinical measurements.
Common side effects
Nausea
Vomiting
Diarrhea
Constipation
Stomach pain
Other risks are listed in the Medication Guide.
Visual: Stable, large type. The music becomes quieter; there is no celebratory or dramatic risk animation.
Boxed warning
Thyroid C-cell tumors in rodents.
Human risk is unknown.
More safety details in the companion notes.
Visual: A dedicated warning panel with no implied human tumor imagery.
HowMedsWork
Read the Medication Guide.
Educational prototype
Visual: Stable ending, with a short fade out.
Read the Ozempic injection Medication Guide in the prescribing information (PDF)
The original short video does not contain all the safety context in this article. Read the selected warnings below and the full Medication Guide.
The pictures and animations are simplified illustrations. They do not show an exact dose, timing, or what will happen for you.
The exact product, age, and condition matter. These are simplified examples from the approved labels.
Ozempic injection is approved alongside diet and exercise to improve blood-sugar control in adults with type 2 diabetes.[1]
Adults with type 2 diabetes; alongside diet and exercise
Sometimes a medicine is prescribed for a use outside its FDA-approved label. That is called “off-label.” It does not mean FDA has approved that use. Here’s the FDA’s explanation.
This first edition does not cover off-label uses for semaglutide. That does not mean none exist.
Semaglutide caused thyroid C-cell tumors in rodents; whether this risk applies to humans is unknown. Ozempic is contraindicated with a personal or family history of medullary thyroid carcinoma, MEN 2, or a serious allergy to semaglutide or its ingredients.[1]
Important risks include pancreatic inflammation, diabetic eye-disease complications, dehydration-related kidney injury, severe digestive reactions, serious allergy, and gallbladder problems. Low blood sugar is more likely with insulin or sulfonylureas. Aspiration has been reported around anesthesia or deep sedation. These are selected risks, not the complete safety information.[1]
Commonly listed side effects include nausea, vomiting, diarrhea, constipation and abdominal pain. Read the Medication Guide for fuller safety information.[1][2]
This is not a complete list of side effects, interactions, or instructions. Read the full label and ask your pharmacist about your prescription.
This explanation focuses on two glucose-control pathways. It is not a guide to every effect, indication or risk of Ozempic injection. The full prescribing information and Medication Guide provide broader context.[1]
Each numbered link points to the source behind the statement. No qualified clinical review recorded.